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Abstract
Background: Meta-analysis of genome-wide association studies identified obesity-related genetic variants. Due to
the pleiotropic effects of related phenotypes, we tested six of these obesity-related genetic variants for their
association with physical activity: fat mass and obesity-associated (FTO)(rs9939609)T>A, potassium channel
tetramerization domain containing (KCTD15) (rs11084753)G>A, melanocortin receptor4 (MC4R)(rs17782313)T>C,
neuronal growth regulator 1 (NEGR1)(rs2815752)A>G, SH2B adapter protein 1 (SH2B1)(rs7498665)A>G, and
transmembrane protein18 (TMEM18)(rs6548238)C>T.
Method: European-American women (n = 263) and men (n = 229) (23.5 ± 0.3 years, 24.6 ± 0.2 kg/m2) were
genotyped and completed the Paffenbarger physical activity Questionnaire. Physical activity volume in metabolic
energy equivalents [MET]-hour/week was derived from the summed time spent (hour/week) times the given MET
value for vigorous, moderate, and light intensity physical activity, and sitting and sleeping, respectively. Multivariable
adjusted [(age, sex, and body mass index (BMI)] linear regression tested associations among genotype (dominant/
recessive model) and the log of physical activity volume.
Result: MC4R (rs17782313)T>C explained 1.1 % (p = 0.02), TMEM18(rs6548238)C>T 1.2 % (p = 0.01), and SH2B1
(rs7498665)A>G 0.6 % (p = 0.08) of the variability in physical activity volume. Subjects with the MC4R C allele spent
3.5 % less MET-hour/week than those with the TT genotype (p = 0.02). Subjects with the TMEM18 T allele spent
4.1 % less MET-hour/week than those with the CC genotype (p = 0.01). Finally, subjects with the SH2B1 GG
genotype spent 3.6 % less MET-hour/week than A allele carriers (p = 0.08).
Conclusion: Our findings suggest a shared genetic influence among some obesity-related gene loci and physical
activity phenotypes that should be explored further. Physical activity volume differences by genotype have public
health importance equating to 11–13 lb weight difference annually.
Key Points
 As we hypothesized, the obesity-related SNPs MC4R
(rs17782313) T>C and TMEM18 (rs6548238) C>T
significantly associated with physical activity volume,
while SH2B1 (rs7498665) A>G trended towards
significance.
 MC4R (rs17782313) T>C, TMEM18 (rs6548238)
C>T, and SH2B1 (rs7498665) A>G accounted for ~1 %
of the variance in physical activity levels each.
 Our findings have public health significance as the
genotype differences in physical activity volume we
found ranged from 10.1 to 11.8 MET-hour/week
equating to a potential weight differential of
10.8–12.7 lb annually.
Background
Overweight and obesity are an epidemic affecting more
than 68.5 % of U.S. adults [1]. To curb this alarming
statistic, a plethora of weight loss strategies have been
proposed ranging from counseling [2] and text messa-
ging [3] to incentivizing [4] and pharmaceutical inter-
ventions [5]. Many of these strategies have proven
efficacious in the short term, but less successful in long-
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term weight loss and maintenance of that weight loss.
Physical activity is not only effective in achieving weight
loss, but also essential in predicting successful weight
loss maintenance [6, 7]. Therefore, the American College
of Sports Medicine (ACSM) recommends 150–250 min/
week of moderate intensity physical activity for weight
loss, and even greater amounts for weight loss mainten-
ance [8, 9]. However, less than half (49.1 %) of U.S.
adults meet the ACSM physical activity recommenda-
tions, and 23.7 % of U.S. adults do not participate in any
leisure time physical activity [10]. Despite the important
role of physical activity in obesity treatment and its
promise for long-term weight loss maintenance, it is not
clear why some individuals are more likely to participate
in habitual physical activity than others to maintain a
healthy body weight.
Twin and family studies have shown that genetic predis-
positions contribute to overweight and obesity [11–15]
with heritability accounting for 37–78 % of the variance in
obesity-related phenotypes. In 2009, the Genetic Investi-
gation of Anthropometric Traits (GIANT) consortium
conducted a meta-analysis of genome-wide association
studies (GWAS) involving 32,387 individuals of European
ancestry and identified eight genetic variants that asso-
ciated with body mass index (BMI) [16]. These single
nucleotide polymorphisms (SNPs) were fat mass and
obesity-associated (FTO) (rs9939609) T>A, glucosamine-6
phosphate deaminase 2 (GNPDA) (rs10938397) A>G,
potassium channel tetramerization domain containing
(KCTD15) (rs11084753) G>A, melanocortin receptor 4
(MC4R) (rs17782313) T>C, mitochondrial carrier homo-
log 2 (MTCH2) (rs10838738) A>G, neuronal growth regu-
lator 1 (NEGR1) (rs2815752) A>G, SH2B adapter protein
1 (SH2B1) (rs7498665) A>G, and transmembrane protein
18 (TMEM18) (rs6548238) C>T.
There is a growing literature showing the important
effect-mediation that physical activity has on the genetic
predispositions to be obese [15, 17–19]. The genetic var-
iants examined in these studies were mainly those iden-
tified in the GWAS by the GIANT consortium to
associate with BMI. We are part of an interdisciplinary
research team that has completed a large exercise genom-
ics study, Functional Single Nucleotide Polymorphisms
Associated with Human Muscle Size and Strength
(FAMuSS, NIH R01 NS40606-02). Our colleague,
Orkunoglu-Suer et al. [20], previously examined the eight
SNPs identified by the GIANT consortium for their associ-
ation with obesity-related phenotypes at baseline and in re-
sponse to resistance training in the FAMuSS cohort. They
found sex-specific associations with MC4R (rs17782313)
T>C and BMI; TMEM18 (rs6548238) C>T and baseline
subcutaneous fat volume; and FTO (rs9939609) T>A and
SH2B1 (rs7498665) A>G and the subcutaneous fat volume
response to resistance training [20].
In our previous work [20] and that of others [15, 17–19],
the effect-medication of physical activity on genetic pre-
dispositions for overweight and obesity was examined.
What was not investigated using this approach is the pos-
sibility of obesity-related SNPs influence physical activity
behavior (Fig. 1). Pleiotropy refers to the shared genetic
influence of related phenotypes [21, 22]. Based upon the
concept of pleiotropy, we speculate that the GWAS-
identified obesity-related SNPs by the GIANT consortium
may associate with physical activity phenotypes. Indeed,
there is biological plausibility for doing so as the GWAS
SNPs found by the GIANT consortium are expressed in
hypothalamus where energy homeostasis is regulated. In
addition, recent work in animals has shown that the con-
trol of voluntary movement resides in similar central
neural pathways as energy intake [23–25]. Therefore, it is
plausible that the central nervous system would be an up-
stream region where these GWAS SNPs share a common
biological influence on both obesity and physical activity
phenotypes.
Fig. 1 A hypothetical model of the pleiotropy between obesity-related gene loci and physical activity phenotypes. a GWAS-identified gene
loci associated with BMI [16]. Two possible explanations supporting the concept of pleiotropy or the shared genetic influence of related
phenotypes: b An individual with genetic predispositions to obesity is less physically active due to their obesity as discussed by Richmond et al.
[33] and others [34, 35]; or (c) an individual with genetic predispositions to be less physically active becomes overweight to obese [32, 37]
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Therefore, the purpose of the present study was to in-
vestigate the six obesity-related SNPs identified in the
GWAS by the GIANT consortium for their association
with habitual physical activity that were in Hardy Weinberg
Equilibrium in the FAMuSS cohort. We hypothesized that
these GWAS obesity-related genetic variants would asso-
ciate with habitual physical activity.
Methods
Overview
This substudy is part of the larger FAMuSS (NIH R01
NS40606-02). FAMuSS was the first systematic study to
examine how physiological responses to resistance train-
ing are modified by genes and the environment [26].
The institutional review boards from the ten institutions
involved with FAMuSS approved the study protocol. All
procedures followed were in accordance with the ethical
standards of the responsible committee on human ex-
perimentation (institutional and national) and with the
Helsinki Declaration of 1975, as revised in 2013. In-
formed consent was obtained from all patients for being
included in the study. The experimental design of
FAMuSS has been described elsewhere so that only the
methods pertaining directly to this substudy will be de-
scribed in detail [26].
Subjects
Potential FAMuSS participants were recruited from the
eight resistance training sites via strategic flyer place-
ment and in-house listserv and radio announcements.
Subjects were excluded if they were <18 or >40 years
and if they were taking any medications known to affect
skeletal muscle function such as corticosteroids, antihy-
pertensive or anti-lipidemic medications, anabolic ste-
roids, diuretics, arthritis medications (Vioxx, Celebrex),
Depo-Provera contraceptive injection, nasal inhalers
(Clenbuterol and Rhinocort), lithium, or chronic use of
non-steroidal anti-inflammatory drugs. In addition, be-
cause the primary aim of FAMuSS was to examine the
influence of genetic variation on the muscle size and
strength response to resistance training, individuals who
reported regular participation in resistance training
within the past 12 months prior to enrollment or per-
formed occupational or recreational physical activity
that involved heavy use of the upper body were also
excluded.
Body Composition
Anthropometric measures were collected using stan-
dardized protocols among the testing sites. Height and
weight were measured using a calibrated wall-mounted
stadiometer and scale, respectively, from which BMI was
calculated (kg/m2).
Physical Activity
Subjects completed the Paffenbarger physical activity
questionnaire during their initial visit to assess weekly
physical activity over the last year. The Paffenbarger
physical activity questionnaire is an eight-item instru-
ment validated among populations similar to the
FAMuSS cohort that is used to measure self-reported
weekly duration and intensity of physical activity [27,
28]. Physical activity volume in metabolic energy equiva-
lents (MET)-hour/week was derived from the summed
time spent (hour/week) times the given MET value for
vigorous, moderate, and light intensity physical activity,
and sitting and sleeping, respectively [29].
Genotyping
A sample of whole blood was obtained from each sub-
ject, refrigerated, and sent to the Children’s National
Medical Center Research (Washington, DC). DNA was
isolated from peripheral blood lymphocytes with the
Gentra Puregene DNA extraction kit (Qiagen, Valencia,
CA) and genotyping was completed using Taqman as-
says from ABI (Foster City, CA). Allele-specific PCR re-
actions for each polymorphism included 20 ng DNA,
900 nM forward and reverse PCR primers, 200 nM
fluorescent allele discrimination probes (common allele
FAM labeled; rare allele VIC labeled), and TaqMan® Uni-
versal PCR Master Mix, No AmpErase® UNG (Applied
Biosystems, Foster City, CA, USA) in a final volume of
25 μl. The PCR and fluorescent ratio profile was gener-
ated after 10 min at 95 °C (denaturation), 44 cycles of
15 s at 92 °C, and 1 min at an annealing temperature of
60 °C. The end point fluorescent readings were analyzed
using an ABI 7900HT and the two alleles were called
using Sequence Detection System (SDS V 2.3 software;
Applied Biosystems, Foster City, CA) and checked
manually [30].
In this substudy, 492 subjects were genotyped for the
following SNPs identified in the GWAS by the GIANT
consortium to associate with BMI that were also in
Hardy Weinberg Equilibrium in the FAMuSS cohort
(Table 1) (13): FTO (rs9939609; n = 483) T>A, KCTD15
(rs11084753; n = 490) G>A, MC4R (rs17782313; n = 480)
T>C, NEGR1 (rs2815752; n = 491) A>G, SH2B1
(rs7498665; n = 489) A>G, and TMEM18 (rs6548238;
n = 490) C>T.
Statistical Analysis
Descriptive analyses were performed for all study vari-
ables. No SNP was in linkage disequilibrium with the
other (r2 < 0.001). To reveal associations among geno-
type (dominant/recessive model) and MET-hour/week,
multivariable adjusted (age, sex, and BMI) linear regres-
sion was used. Then the partial (Type-3) R-square values
for the independent variables were computed. In the
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regression model, log-transformation was considered for
the physical activity volume outcome variable to satisfy
the underlying assumption (=normality). To estimate the
actual MET-hour/week difference among genotypes, the
coefficient obtained from the regression model was back
transformed (e.g., e-0.036 = 0.964), and multiplied by the
mean MET-h∙wk−1 (i.e., 287.4 MET-hour/week) among
the FAMuSS cohort (Table 2). Linear regression analyses
were performed using the R Core Team (2015) for
Windows (Vienna, Austria); and descriptive statistics were
performed using the Statistical Package for the Social Sci-
ences (SPSS) 14.0 for Windows (Chicago, IL, USA). We
ran a power calculation based on the R-square difference
between the full model vs. the three genetic variants
(MC4R, TMEM18, SH2B1) using Statistical Analysis
System (SAS) 9.1.3 for Windows (Cary, NC, USA).
Accordingly, we had 92.5 % power with an alpha
<0.05 to detect phenotype–genotype differences with
three genetic variants and physical activity volume.
Results
Subject Characteristics
The sample consisted of healthy, young European-
American men and women (Table 2) with a BMI level
that reflected the larger FAMuSS cohort [20, 26], and
the general age-matched population from which they
were recruited [1]. While age did not differ by sex (p >
0.05), men had a higher BMI than women (p < 0.001).
The self-reported sitting time (6.4 h/day or 40 % of wak-
ing time) among this FAMuSS subsample was slightly
lower than the average American adults’ sitting time
(60 % of waking time) [31].
Genetic Predictors of Physical Activity Volume
(MET-hour/week)
Multivariable linear regression model revealed that
MC4R (rs17782313) T>C (p = 0.02) and TMEM18
(rs6548238) C>T (p = 0.01) were significant predictors of
physical activity volume, while SH2B1 (rs7498665) A>G
trended towards significance (p = 0.08). MC4R
(rs17782313) T>C explained 1.1 % (p = 0.02), TMEM18
(rs6548238) C>T explained 1.2 % (p = 0.01), and SH2B1
(rs7498665) A>G explained 0.6 % (p = 0.08) of the vari-
ability in physical activity volume.
Genotype and Physical Activity Phenotype Associations
MC4R (rs17782313) T>C
Subjects with the MC4R CC genotype spent 3.5 % less
MET-hour/week than T allele carriers (p = 0.02). Given
the mean value of physical activity volume for the sam-
ple (Table 2), a 3.5 % reduction in MET-hour/week
among subjects with the MC4R CC genotype equates to
a 10.1 MET-hour/week decrease in physical activity vol-
ume for those with the CC genotype compared to T al-
lele carriers.
TMEM18 (rs6548238) C>T
Subjects with the TMEM18 T allele spent 4.1 % less
MET-hour/week than those with the CC genotype (p =
0.01). Given the mean value of physical activity volume
for the sample, (Table 2), a 4.1 % reduction in MET-
hour/week among TMEM18 T allele carriers equates to
a 11.8 MET-hour/week decrease in physical activity vol-
ume for the T allele carriers compared to those with the
CC genotype.
SH2B1 (rs7498665) A>G
Finally, subjects with the SH2B1 GG genotype spent
3.6 % less MET-hour/week than A allele carriers (p =
0.08). Given the mean value of physical activity volume
for the sample (Table 2), a 3.6 % reduction among sub-
jects with the SH2B1 GG genotype equates to 10.3
MET-hour/week decrease in physical activity volume
for those with the GG genotype compared to A allele
carriers.
Table 2 Subject characteristics and self-reported physical activity levels
Characteristics Total sample Women Men
(n = 492) (n = 263) (n = 229)
Age (year) 23.5 ± 0.3 23.2 ± 0.4 23.9 ± 0.4
Body mass index (kg/m)* 24.6 ± 0.2 23.9 ± 0.3 25.4 ± 0.3
Physical activity volume (MET-hour/week) 287.4 ± 2.2 288.5 ± 2.7 286.1 ± 3.7
Values are presented as mean ± standard error
*p = 0.001 (women vs men)
Table 1 Chi-square (χ2) and allelic frequencies of single
nucleotide polymorphisms examined in the current study
Nearest gene RefSeq# Alleles (+/−) χ2 p q p value
FTO rs9939609 T/A 0.74 0.40 0.60 0.39
MC4R rs17782313 T/C 0.04 0.21 0.79 0.83
NEGR1 rs2815752 A/G 0.71 0.65 0.35 0.39
SH2B1 rs7498665 A/G 0.04 0.61 0.39 0.84
KCTD15 rs11084753 G/A 0.02 0.66 0.34 0.88
TMEM18 rs6548238 C/T 0.08 0.82 0.18 0.78
FTO fat mass and obesity-associated gene, MC4R Melanocortin 4 receptor,
NEGR1 neuronal growth regulator 1, KCTD15 potassium channel tetramerization
domain containing 15, SH2B1 Src homology 2 B adapter protein 1, TMEM18
transmembrane protein 18. df = 1 for all analyses
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Discussion
We tested six SNPs associated with obesity from GWAS
by the GIANT consortium for their association with
physical activity volume in the FAMuSS cohort. MC4R
(rs17782313) T>C (p = 0.02) and TMEM18 (rs6548238)
C>T (p = 0.01) were significant predictors of physical ac-
tivity volume, while SH2B1 (rs7498665) A>G trended to-
wards significance (p = 0.08). These GWAS obesity-
related genotype and physical activity volume associa-
tions accounted for ~1 % of the variance in the physical
activity volume each. The genotype differences in phys-
ical activity volume that we found ranged from 10.1 to
11.8 MET-hour/week (i.e., 730 to 850 kcal/week assum-
ing a mean sample body weight of 72.3 kg) and could
theoretically amount to a weight differential of 10.8–
12.7 lb per year (i.e., assuming 3500 kcal = 1 lb fat mass).
Our results support the notion of genetic pleiotropy or
the shared genetic influence among obesity and physical
activity phenotypes that should be explored further [22].
Furthermore, the genotype differences we found in
weekly physical activity volume have important public
health implications for maintaining a healthy weight.
Our finding with MC4R (rs17782313) T>C and its as-
sociation with physical activity is consistent with a prior
report that this is an important obesity susceptibility
genetic locus that also associates with physical activity.
Loos et al. [32] examined whether MC4R (rs17782313)
T>C influenced self-reported physical activity among
parents (n = 326, 52 ± 3.4 years) and their offspring (n =
343, 28 ± 8.7 years) who were overweight in the Quebec
Family Study. The parents with the MC4R (rs17782313)
CC genotype reported engaging in 986.1 kcal/week less
in moderate-to-vigorous sports and recreation than sub-
jects with the CT genotype and 1500.6 kcal/week less
than the T allele carriers. Similar to Loos et al. [32],
FAMuSS subjects with the MC4R (rs17782313) CC
genotype spent less weekly physical activity volume than
T allele carriers. TMEM18 (rs6548238) C>T and SH2B1
(rs7498665) A>G have not yet been examined for their
associations with physical activity other than in the
FAMuSS cohort, so comparisons to the published litera-
ture are not possible.
The biological mechanisms by which SNPs identified
in GWAS to associate with obesity-related phenotypes
may modulate physical activity are largely unknown. In
addition, our findings are based on association and not
causation. Nonetheless, as illustrated in Fig. 1, we
propose two plausible explanations for the associations
we observed: 1) an individual with genetic predisposi-
tions to obesity [16] is less physically active due to their
obesity as discussed by Richmond et al [33] and others
[34, 35] (Fig. 1b); or 2) an individual with genetic predis-
positions to be less physically active becomes overweight
to obese (Fig. 1c). Although we acknowledge both
explanations are possible, the biological features of the
SNPs we examined appear to support the second explan-
ation. In addition, Orkunoglu-Suer et al. [20] found that
the same three SNPs that associated with physical activ-
ity volume in our study [i.e., MC4R (rs17782313) T>C,
TMEM18 (rs6548238) C>T, and SH2B1 (rs7498665)
A>G] also associated with body composition phenotypes
including BMI among the FAMuSS cohort further sub-
stantiating the concept of pleiotropy and our hypothesis
of the essential role that physical activity has in mediat-
ing overweight and obesity.
It is interesting to note that the three SNPs that we
and Okkunoglu-Suer et al. [20] examined are expressed
in brain and/or hypothalamus where energy homeostasis
is regulated [16]. The hypothalamus is the primary out-
put node for the limbic system, which is responsible for
endocrine function and behavior reinforcement. The
limbic system is implicated in the control of food pro-
curement as an evolutionarily conserved survival mech-
anism to defend against famine [36]. In this regard,
these three GIANT consortium identified GWAS obesity
SNPs that we found to be associated with physical activ-
ity and Orkunoglu-Suer et al. found to be associated
with body composition phenotypes [20] have been classi-
fied as hyperphagic genes related to appetite suppression
and satiety whose regulation resides in the dopaminergic
projection from the limbic system [37–39]. Recent re-
search in animals suggests that the ‘pleasure-reward’ sys-
tem residing in the dopaminergic pathway that regulates
appetite and satiety has a key role in voluntary move-
ment [25, 40] and heightened reward sensitivity in ani-
mals with obesity that binge eat [41, 42]. The apparent
shared genetic influence of energy intake and expend-
iture whose regulation resides in similar central nervous
system pathways, particularly in the hypothalamus and
dopaminergic pathway, is noteworthy, supports our hy-
pothesis, and merits further investigation.
This study has several limitations as this was a sub-
study of FAMuSS whose primary purpose was to exam-
ine the influence of genetic variation on the muscle
size and strength response to resistance training. The
FAMuSS cohort consisted primarily of healthy, European-
American young adults with the characteristics of the sub-
jects in this substudy mirroring those of the larger cohort
(Table 3). The physical activity data we collected with the
Paffenbarger physical activity questionnaire were suscep-
tible to subject recall and social desirability bias [43], and
there were no measures of reproducibility and validity
about the Paffenbarger’s questionnaire in our sample.
However, the Paffenbarger physical activity questionnaire
is a well validated and reliable method for assessing leisure
time physical activity in similar populations to the present
study [44]. Our only measure of body composition was
BMI which does not discriminate among body fat, muscle
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mass, or bone [45]. Last, we did not measure energy in-
take nor did we obtain physiological data that would pro-
vide insight into mechanisms for the genotype–physical
activity phenotype associations we found.
Yet, this study has several important strengths. FAMuSS
is recognized as one of the largest exercise genomics stud-
ies ever conducted [46]. In addition, physical activity is
more heritable among young than older adults [47].
Therefore, as the average age of the FAMuSS subjects was
24 years, the heritability of their habitual physical activity
levels was not confounded with the influence of age that
may have contributed to us finding the genotype–physical
activity phenotype associations we observed.
Conclusion
In summary, we have shown that three genetic variants
associated with obesity in GWAS by the GIANT consor-
tium also associated with habitual physical activity in the
FAMuSS cohort. These SNPs accounted for ~1 % of the
variance in physical activity levels each. The genotype
differences in physical activity volume we found ranged
from 10.1 to 11.8 MET-hour/week equating to a poten-
tial weight differential of 10.8–12.7 lb annually. Our
findings suggest obesity and physical activity have a
shared genetic influence that is regulated by common
central neural pathways that merit further investigation.
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Table 3 Genotype frequencies of single nucleotide














MC4R rs17782313 T/C C 0.790 0.735
TMEM18 rs6548238 C/T C 0.824 0.850
FTO rs9939609 T/A A 0.395 0.460
NEGR1 rs2815752 A/G A 0.650 0.637
SH2B1 rs7498665 A/G G 0.392 0.381
KCTD15 rs11084753 G/A G 0.664 0.690
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